Multiple Sclerosis and Related Disorders

Multiple Sclerosis and Related Disorders

How to individualize MS treatment decisions? 12:15
How to individualize MS treatment decisions?
Mar Tintoré • 7 Jun 2021
BTK inhibitors gain ground in MS 1:27
BTK inhibitors gain ground in MS
Nikolaos Grigoriadis • 8 Jun 2021
CASTING: ocrelizumab safety profile in RRMS 2:16
CASTING: ocrelizumab safety profile in RRMS
Celia Oreja-Guevara • 20 Jun 2021
Outcomes in newborns of mothers with MS 1:32
Outcomes in newborns of mothers with MS
Celia Oreja-Guevara • 20 Jun 2021
Effect of MS on COVID-19 infection and vaccination 3:00
Effect of MS on COVID-19 infection and vaccination
Celia Oreja-Guevara • 20 Jun 2021
Personalized medicine: an important step in the management of MS 1:50
Personalized medicine: an important step in the management of MS
Celia Oreja-Guevara • 20 Jun 2021
Oral treatments for MS: S1P modulators 2:26
Oral treatments for MS: S1P modulators
Celia Oreja-Guevara • 20 Jun 2021
MS research from EAN 2021 2:11
MS research from EAN 2021
Massimo Filippi • 17 Jun 2021
Future evolutions of the McDonald criteria 2:11
Future evolutions of the McDonald criteria
Massimo Filippi • 17 Jun 2021
Comparison of the 2017 and 2010 revisions of the McDonald criteria: MAGNIMS study 3:35
Comparison of the 2017 and 2010 revisions of the McDonald criteria: MAGNIMS study
Massimo Filippi • 17 Jun 2021
NfL to monitor treatment effects in MS 3:26
NfL to monitor treatment effects in MS
Charlotte Teunissen • 4 Jun 2021
Novel biomarkers to predict progression in MS 4:28
Novel biomarkers to predict progression in MS
Charlotte Teunissen • 4 Jun 2021
Impact of cardiovascular risk factors on young MS 2:16
Impact of cardiovascular risk factors on young MS
Raffaello Bonacchi • 3 Jun 2021
Using MRI to identify MS pathology in the cerebellum 2:04
Using MRI to identify MS pathology in the cerebellum
Raffaello Bonacchi • 3 Jun 2021
Impact of age of onset on MRI metrics in MS 3:03
Impact of age of onset on MRI metrics in MS
Raffaello Bonacchi • 3 Jun 2021
Future of secondary progressive MS diagnosis and treatment 2:50
Future of secondary progressive MS diagnosis and treatment
Dana Horakova • 2 Jun 2021
The content of VJNeurology is intended for healthcare professionals